Natalie Sacks is Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP). They have made 12 open-market trades across 2 companies since 2017, most recently 2020-05-18.
CIK 0001683811
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HARP | SELL · 10b5-1 | 2020-05-18 | 2020-05-20 | $14.77 | $22K | -7.4% | -8.3% | -40.5% |
| HARP | SELL | 2020-05-01 | 2020-05-05 | $12.07 | $141K | +6.9% | +28.2% | -10.8% |
| HARP | SELL · 10b5-1 | 2020-04-16 | 2020-04-17 | $12.05 | $18K | +5.4% | +24.5% | +18.0% |
| HARP | SELL | 2020-04-13 | 2020-04-15 | $12.06 | $110K | +14.4% | +20.3% | +25.5% |
| HARP | SELL · 10b5-1 | 2020-04-06 | 2020-04-08 | $12.00 | $15K | +6.2% | +15.3% | +41.2% |
| HARP | SELL · 10b5-1 | 2020-03-16 | 2020-03-18 | $12.00 | $18K | -2.5% | +5.0% | +49.3% |
| HARP | SELL | 2020-03-02 | 2020-03-03 | $14.68 | $171K | -22.4% | -28.2% | +15.8% |
| HARP | SELL · 10b5-1 | 2020-02-18 | 2020-02-20 | $15.00 | $23K | +1.9% | -26.0% | +27.5% |
| HARP | SELL | 2020-02-03 | 2020-02-04 | $13.90 | $162K | +1.6% | +5.1% | -9.5% |
| HARP | SELL · 10b5-1 | 2020-01-16 | 2020-01-21 | $14.94 | $23K | -6.1% | +6.7% | -8.1% |
| HARP | SELL | 2020-01-02 | 2020-01-06 | $14.18 | $165K | +4.2% | +14.1% | -16.1% |
| HARP | SELL · 10b5-1 | 2019-12-16 | 2019-12-18 | $17.02 | $26K | -17.4% | -19.0% | -30.6% |
| HARP | SELL | 2019-12-02 | 2019-12-04 | $17.98 | $210K | -5.8% | -19.9% | -14.9% |
| HARP | SELL | 2019-11-18 | 2019-11-19 | $13.35 | $474K | +15.4% | +22.4% | +2.4% |
| HARP | SELL | 2019-11-01 | 2019-11-05 | $13.17 | $153K | +0.3% | +30.5% | +2.0% |
| HARP | SELL | 2019-10-14 | 2019-10-16 | $13.24 | $640K | +4.3% | +3.5% | +11.5% |
| ADRO | SELL | 2018-09-13 | 2018-09-14 | $6.50 | $20K | -11.8% | -6.0% | -59.9% |
| ADRO | SELL | 2018-09-04 | 2018-09-06 | $7.13 | $32K | -13.5% | -21.8% | -63.1% |
| ADRO | SELL | 2017-09-01 | 2017-09-06 | $11.71 | $114K | -4.3% | -11.2% | -26.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.